IT1244743B - Medicamento per il trattamento della dermatite - Google Patents

Medicamento per il trattamento della dermatite

Info

Publication number
IT1244743B
IT1244743B ITMI910381A ITMI910381A IT1244743B IT 1244743 B IT1244743 B IT 1244743B IT MI910381 A ITMI910381 A IT MI910381A IT MI910381 A ITMI910381 A IT MI910381A IT 1244743 B IT1244743 B IT 1244743B
Authority
IT
Italy
Prior art keywords
treatment
dermatitis
klebsiella
medication
catarrhalis
Prior art date
Application number
ITMI910381A
Other languages
English (en)
Inventor
Courten Alfred De
Jean-Claude Farine
Original Assignee
Om Lab Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Om Lab Sa filed Critical Om Lab Sa
Publication of ITMI910381A0 publication Critical patent/ITMI910381A0/it
Publication of ITMI910381A1 publication Critical patent/ITMI910381A1/it
Application granted granted Critical
Publication of IT1244743B publication Critical patent/IT1244743B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

La presente invenzione concerne l'utilizzazione di un lisato batterico sotto forma concentrato e liofilizzato proveniente da uno dei seguenti ceppi: Haemophilus influenzae (serotipe b), Diplococcus pneumoniae (serotipi 1, 2, 3, 47), Klebsiella pneumoniae, Klebsiella ozaenac, Staphylococcus aureus, Streptococcus viridans, Streptococcus pyogenes (serogroupe A), Branhamella catarrhalis (anc. Neisseria catarrhalis), per la fabbricazione di un medicamento destinato al trattamento della dermatite atopica.
ITMI910381A 1990-02-16 1991-02-14 Medicamento per il trattamento della dermatite IT1244743B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH497/90A CH680045A5 (it) 1990-02-16 1990-02-16

Publications (3)

Publication Number Publication Date
ITMI910381A0 ITMI910381A0 (it) 1991-02-14
ITMI910381A1 ITMI910381A1 (it) 1992-08-14
IT1244743B true IT1244743B (it) 1994-08-08

Family

ID=4188357

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI910381A IT1244743B (it) 1990-02-16 1991-02-14 Medicamento per il trattamento della dermatite

Country Status (13)

Country Link
JP (1) JP3002552B2 (it)
KR (1) KR0169982B1 (it)
AT (1) AT402152B (it)
BE (1) BE1005589A3 (it)
CH (1) CH680045A5 (it)
DE (1) DE4104728C2 (it)
EG (1) EG19540A (it)
FR (1) FR2658419B1 (it)
GB (1) GB2240922A (it)
HU (1) HU210834B (it)
IT (1) IT1244743B (it)
PL (1) PL289084A1 (it)
PT (1) PT96789B (it)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2098109C1 (ru) * 1996-09-26 1997-12-10 Александр Григорьевич Чучалин Противоаллергическое, противовоспалительное средство, способ его получения, лечебное и косметическое средства с его использованием
WO1999048510A1 (en) * 1998-03-24 1999-09-30 Tayca Corporation Immunoglobulin m antibody production inhibitor and anti-rheumatoid arthritis drug
WO2004112833A1 (en) 2003-06-23 2004-12-29 Biotech Tools Sa Epitope composition for sublingual, buccal or enteric administration prepared by hydrolysis of antigenic structures with chymotrypsin
UA72065C2 (en) * 2004-09-10 2005-01-17 Viridans Ltd Liability Company Strain aerococcus viridans 167k imb b-7069 with antibacterial activity and "viabac" preparation comprising this strain
FR2969657B1 (fr) 2010-12-22 2014-02-07 Fabre Pierre Dermo Cosmetique Nouvelle bacterie et extraits de ladite bacterie et leur utilisation en dermatologie
GB201318170D0 (en) * 2013-10-14 2013-11-27 Univ Edinburgh Proteins with Diagnostic and Therapeutic Uses
KR102437436B1 (ko) 2019-04-26 2022-08-30 주식회사 엠디헬스케어 스트렙토코커스 파이오제네스 세균 유래 단백질 및 이의 용도
EP3960191A4 (en) * 2019-04-26 2023-01-04 MD Healthcare Inc. PROTEIN DERIVED FROM STREPTOCOCCUS PYOGENES BACTERIA AND ITS USE

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH633188A5 (fr) * 1978-05-26 1982-11-30 Om Laboratoires Sa Medicament contre des maladies infectieuses des voies respiratoires.

Also Published As

Publication number Publication date
FR2658419A1 (fr) 1991-08-23
EG19540A (en) 1995-08-30
FR2658419B1 (fr) 1995-01-27
HU210834B (en) 1995-08-28
HUT61201A (en) 1992-12-28
BE1005589A3 (fr) 1993-11-16
ITMI910381A1 (it) 1992-08-14
ATA32291A (de) 1996-07-15
KR0169982B1 (ko) 1999-02-01
PT96789A (pt) 1991-10-31
DE4104728A1 (de) 1991-08-22
JPH04211017A (ja) 1992-08-03
AT402152B (de) 1997-02-25
ITMI910381A0 (it) 1991-02-14
JP3002552B2 (ja) 2000-01-24
KR910015306A (ko) 1991-09-30
GB9103278D0 (en) 1991-04-03
GB2240922A (en) 1991-08-21
CH680045A5 (it) 1992-06-15
HU910511D0 (en) 1991-09-30
DE4104728C2 (de) 1999-01-14
PL289084A1 (en) 1991-11-04
PT96789B (pt) 1998-08-31

Similar Documents

Publication Publication Date Title
Watanakunakorn Mode of action and in-vitro activity of vancomycin
Manders Toxin-mediated streptococcal and staphylococcal disease
DE69527195D1 (de) Anti gram positive bakterielle verfahren und mittel
EP0665754A4 (en) ANTIMICROBIAL POLYPEPTIDES.
Gill et al. Changing patterns of bacterial resistance to antimicrobial drugs
CA2031803A1 (en) Improvements in or relating to glycopeptide deriveratives
AU7792294A (en) Antibacterial composition containing multimeric alpha-lactalbumin
Segev et al. Double-blind randomized study of 1 g versus 2 g intravenous ceftriaxone daily in the therapy of community-acquired infections
KR910015306A (ko) 피부염 치료용 약제
Ginsburg Streptococcus.
Bernard et al. In Vivo Selection of Streptococcus pneumoniae, Resistant to Quinolones, Including Sparfloxin
Dashefsky et al. The treatment of bacterial infections in the newborn infant
Anzueto et al. Safety and efficacy of clarithromycin vs cefuroxime axetil in the treatment of acute bacterial exacerbation of chronic bronchitis.
Uezumi et al. Effects of a human antiflagellar monoclonal antibody in combination with antibiotics on Pseudomonas aeruginosa infection
Appelbaum et al. Septicemia due to Streptococcus equisimilis in a child with acute lymphoblastic leukemia
D'Antonio et al. Comparison of norfloxacin and pefloxacin in the prophylaxis of bacterial infection in neutropenic cancer patients
JP2004507440A5 (it)
ES8707251A1 (es) Un metodo para producir n-desacetil-antibiotico tan-588
Shimada et al. Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (2000)
Farhadi et al. BACTERIAL ETIOLOGIES AND ANTIBIOTIC RESISTANCE IN SINUSITIS: A STUDY OF 264 CASES
Feder Jr et al. Group A streptococcal multifocal septic arthritis: a case report
FI864769L (fi) Icke-adjuvanserad vaccin.
Sugita et al. Clinical efficacy in pediatrics sinusitis infections of cefditoren pivoxil granule therapy and its in vitro antibacterial activity against clinically isolated strains
Asahi et al. Nasopharyngeal flora and carriage rates of Haemophilus influenzae type b of healthy infants
Dalhoff Opportunistic Infections caused by Pseudomonas aeruginosa.

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19960209